STOCK TITAN

Voyager Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Voyager Therapeutics (Nasdaq: VYGR) announced its participation in two upcoming investor conferences. The first is Chardan’s 6th Annual Genetic Medicines Conference on October 4, 2022, featuring a company presentation at 3:45 p.m. ET. The second event is the Truist Securities Genetic Medicine Summit on October 20, 2022, where Voyager will participate in a CNS panel discussion (not webcast). Interested investors can access the presentation and archived webcasts on Voyager's website for 30 days following the events.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a gene therapy and neuroscience company developing life-changing treatments and next-generation adeno-associated virus (AAV) capsids, today announced that management will participate in the following investor conferences:

  • Chardan’s 6th Annual Genetic Medicines Conference, New York, NY – Company presentation, October 4, 2022, 3:45 p.m. ET
  • Truist Securities Genetic Medicine Summit, New York, NY – CNS panel discussion (not webcast), October 20, 2022

The presentation may be accessed from the Investors section of Voyager’s website at www.voyagertherapeutics.com. Replays of webcasts are archived on the Company's website for at least 30 days.

AboutVoyager Therapeutics 
Voyager Therapeutics (Nasdaq: VYGR) is leading the next generation of AAV gene therapy to unlock the potential of the modality to treat devastating diseases. Proprietary capsids born from Voyager’s TRACER capsid discovery platform are powering a rich early-stage pipeline of programs and may elevate the field to overcome the narrow therapeutic window associated with conventional gene therapy vectors across neurologic disorders and other therapeutic areas.
voyagertherapeutics.com        LinkedIn        Twitter 

Voyager Therapeutics® is a registered trademark, and TRACER™ is a trademark, of Voyager Therapeutics, Inc. 


FAQ

When is Voyager Therapeutics' presentation at Chardan’s Genetic Medicines Conference?

Voyager Therapeutics will present at Chardan’s 6th Annual Genetic Medicines Conference on October 4, 2022, at 3:45 p.m. ET.

What is the date of the Truist Securities Genetic Medicine Summit?

The Truist Securities Genetic Medicine Summit is scheduled for October 20, 2022.

Where can I access Voyager Therapeutics' conference presentations?

Presentations can be accessed from the Investors section of Voyager Therapeutics' website.

Will the CNS panel discussion at the Truist Securities Summit be webcast?

No, the CNS panel discussion at the Truist Securities Genetic Medicine Summit will not be webcast.

What is the stock symbol for Voyager Therapeutics?

The stock symbol for Voyager Therapeutics is VYGR.

Voyager Therapeutics, Inc.

NASDAQ:VYGR

VYGR Rankings

VYGR Latest News

VYGR Stock Data

310.82M
45.35M
16.98%
65.48%
4.47%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
LEXINGTON